Last 12 months
Inside the activity.
0 purchase rows · 204 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 17 |
| Dec 2025 | 0 | 26 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 2 |
| Mar 2026 | 0 | 1 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 8 |
| Jun 2026 | 0 | 32 |
| Jul 2026 | 0 | 64 |
| Aug 2026 | 0 | 27 |
| Sep 2026 | 0 | 20 |
| Oct 2026 | 0 | 5 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 28, 2018 Filed Nov 29, 2018 00:26 UTC |
OYLER JOHNDirector · Chief Executive Officer
|
SaleAmerican Depositary Shares | 2,575 | $146.70 | $377,749.15 |
DisclosureSEC source: 0001651308-18-000010 · wf-form4_154345117115026.xml · nonDerivative · entry 23 OYLER JOHN · CIK 0001042047 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 8,128 F5 · security: Each American Depositary Share represents 13 Ordinary Shares. F6 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F24 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $146.31 to $147.3099, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares, sold at each separate price. F1 · ownership.nature: These securities are held by Oyler Investment LLC, of which 99% of the limited liability company interest is owned by a grantor retained annuity trust, of which the Reporting Person's father is a trustee, for which the Reporting Person disclaims beneficial ownership. Read SEC document |
| November 28, 2018 Filed Nov 29, 2018 00:26 UTC |
OYLER JOHNDirector · Chief Executive Officer
|
SaleAmerican Depositary Shares | 1,000 | $145.87 | $145,865.00 |
DisclosureSEC source: 0001651308-18-000010 · wf-form4_154345117115026.xml · nonDerivative · entry 22 OYLER JOHN · CIK 0001042047 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 10,703 F5 · security: Each American Depositary Share represents 13 Ordinary Shares. F6 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F23 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $145.28 to $146.2799, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares, sold at each separate price. F1 · ownership.nature: These securities are held by Oyler Investment LLC, of which 99% of the limited liability company interest is owned by a grantor retained annuity trust, of which the Reporting Person's father is a trustee, for which the Reporting Person disclaims beneficial ownership. Read SEC document |
| November 28, 2018 Filed Nov 29, 2018 00:26 UTC |
OYLER JOHNDirector · Chief Executive Officer
|
SaleAmerican Depositary Shares | 800 | $144.75 | $115,798.48 |
DisclosureSEC source: 0001651308-18-000010 · wf-form4_154345117115026.xml · nonDerivative · entry 21 OYLER JOHN · CIK 0001042047 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 11,703 F5 · security: Each American Depositary Share represents 13 Ordinary Shares. F6 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F22 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $144.28 to $145.2799, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares, sold at each separate price. F1 · ownership.nature: These securities are held by Oyler Investment LLC, of which 99% of the limited liability company interest is owned by a grantor retained annuity trust, of which the Reporting Person's father is a trustee, for which the Reporting Person disclaims beneficial ownership. Read SEC document |
| November 28, 2018 Filed Nov 29, 2018 00:26 UTC |
OYLER JOHNDirector · Chief Executive Officer
|
SaleAmerican Depositary Shares | 500 | $143.71 | $71,855.00 |
DisclosureSEC source: 0001651308-18-000010 · wf-form4_154345117115026.xml · nonDerivative · entry 20 OYLER JOHN · CIK 0001042047 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 12,503 F5 · security: Each American Depositary Share represents 13 Ordinary Shares. F6 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F21 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $143.24 to $144.2399, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares, sold at each separate price. F1 · ownership.nature: These securities are held by Oyler Investment LLC, of which 99% of the limited liability company interest is owned by a grantor retained annuity trust, of which the Reporting Person's father is a trustee, for which the Reporting Person disclaims beneficial ownership. Read SEC document |
| November 27, 2018 Filed Nov 29, 2018 00:26 UTC |
OYLER JOHNDirector · Chief Executive Officer
|
SaleAmerican Depositary Shares | 800 | $146.41 | $117,126.96 |
DisclosureSEC source: 0001651308-18-000010 · wf-form4_154345117115026.xml · nonDerivative · entry 19 OYLER JOHN · CIK 0001042047 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 13,003 F5 · security: Each American Depositary Share represents 13 Ordinary Shares. F6 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F20 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $146.06 to $147.0599, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares, sold at each separate price. F1 · ownership.nature: These securities are held by Oyler Investment LLC, of which 99% of the limited liability company interest is owned by a grantor retained annuity trust, of which the Reporting Person's father is a trustee, for which the Reporting Person disclaims beneficial ownership. Read SEC document |
| November 27, 2018 Filed Nov 29, 2018 00:26 UTC |
OYLER JOHNDirector · Chief Executive Officer
|
SaleAmerican Depositary Shares | 4,148 | $145.37 | $603,013.01 |
DisclosureSEC source: 0001651308-18-000010 · wf-form4_154345117115026.xml · nonDerivative · entry 18 OYLER JOHN · CIK 0001042047 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 13,803 F5 · security: Each American Depositary Share represents 13 Ordinary Shares. F6 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F19 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $145.00 to $145.9999, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares, sold at each separate price. F1 · ownership.nature: These securities are held by Oyler Investment LLC, of which 99% of the limited liability company interest is owned by a grantor retained annuity trust, of which the Reporting Person's father is a trustee, for which the Reporting Person disclaims beneficial ownership. Read SEC document |
| November 27, 2018 Filed Nov 29, 2018 00:26 UTC |
OYLER JOHNDirector · Chief Executive Officer
|
SaleAmerican Depositary Shares | 3,475 | $144.62 | $502,545.12 |
DisclosureSEC source: 0001651308-18-000010 · wf-form4_154345117115026.xml · nonDerivative · entry 17 OYLER JOHN · CIK 0001042047 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 17,951 F5 · security: Each American Depositary Share represents 13 Ordinary Shares. F6 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F18 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $143.99 to $144.9899, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares, sold at each separate price. F1 · ownership.nature: These securities are held by Oyler Investment LLC, of which 99% of the limited liability company interest is owned by a grantor retained annuity trust, of which the Reporting Person's father is a trustee, for which the Reporting Person disclaims beneficial ownership. Read SEC document |
| November 27, 2018 Filed Nov 29, 2018 00:26 UTC |
OYLER JOHNDirector · Chief Executive Officer
|
SaleAmerican Depositary Shares | 1,629 | $143.67 | $234,039.90 |
DisclosureSEC source: 0001651308-18-000010 · wf-form4_154345117115026.xml · nonDerivative · entry 16 OYLER JOHN · CIK 0001042047 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 21,426 F5 · security: Each American Depositary Share represents 13 Ordinary Shares. F6 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F17 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $142.99 to $143.9899, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares, sold at each separate price. F1 · ownership.nature: These securities are held by Oyler Investment LLC, of which 99% of the limited liability company interest is owned by a grantor retained annuity trust, of which the Reporting Person's father is a trustee, for which the Reporting Person disclaims beneficial ownership. Read SEC document |
| November 27, 2018 Filed Nov 29, 2018 00:26 UTC |
OYLER JOHNDirector · Chief Executive Officer
|
SaleAmerican Depositary Shares | 800 | $142.35 | $113,880.00 |
DisclosureSEC source: 0001651308-18-000010 · wf-form4_154345117115026.xml · nonDerivative · entry 15 OYLER JOHN · CIK 0001042047 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 23,055 F5 · security: Each American Depositary Share represents 13 Ordinary Shares. F6 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F16 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $141.90 to $142.8999, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares, sold at each separate price. F1 · ownership.nature: These securities are held by Oyler Investment LLC, of which 99% of the limited liability company interest is owned by a grantor retained annuity trust, of which the Reporting Person's father is a trustee, for which the Reporting Person disclaims beneficial ownership. Read SEC document |
| November 27, 2018 Filed Nov 29, 2018 00:26 UTC |
OYLER JOHNDirector · Chief Executive Officer
|
SaleAmerican Depositary Shares | 200 | $141.12 | $28,224.00 |
DisclosureSEC source: 0001651308-18-000010 · wf-form4_154345117115026.xml · nonDerivative · entry 14 OYLER JOHN · CIK 0001042047 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 23,855 F5 · security: Each American Depositary Share represents 13 Ordinary Shares. F6 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F15 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $140.71 to $141.7099, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares, sold at each separate price. F1 · ownership.nature: These securities are held by Oyler Investment LLC, of which 99% of the limited liability company interest is owned by a grantor retained annuity trust, of which the Reporting Person's father is a trustee, for which the Reporting Person disclaims beneficial ownership. Read SEC document |
| November 27, 2018 Filed Nov 29, 2018 00:26 UTC |
OYLER JOHNDirector · Chief Executive Officer
|
SaleAmerican Depositary Shares | 200 | $139.57 | $27,914.00 |
DisclosureSEC source: 0001651308-18-000010 · wf-form4_154345117115026.xml · nonDerivative · entry 13 OYLER JOHN · CIK 0001042047 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 24,055 F5 · security: Each American Depositary Share represents 13 Ordinary Shares. F6 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F14 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $139.56 to $140.5599, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares, sold at each separate price. F1 · ownership.nature: These securities are held by Oyler Investment LLC, of which 99% of the limited liability company interest is owned by a grantor retained annuity trust, of which the Reporting Person's father is a trustee, for which the Reporting Person disclaims beneficial ownership. Read SEC document |
| November 27, 2018 Filed Nov 29, 2018 00:23 UTC |
Wang XiaodongDirector
|
GiftOrdinary Shares | 89,999 | $0.00 | $0.00 |
DisclosureSEC source: 0001651308-18-000008 · wf-form4_154345100369618.xml · nonDerivative · entry 1 Wang Xiaodong · CIK 0001662982 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,773,608 F1 · price: Bona fide gift of shares which is exempt from Section 16(b) of the Exchange Act pursuant to Rule 16b-5. Read SEC document |
| November 26, 2018 Filed Nov 29, 2018 00:26 UTC |
OYLER JOHNDirector · Chief Executive Officer
|
SaleAmerican Depositary Shares | 805 | $141.98 | $114,292.93 |
DisclosureSEC source: 0001651308-18-000010 · wf-form4_154345117115026.xml · nonDerivative · entry 12 OYLER JOHN · CIK 0001042047 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 24,255 F5 · security: Each American Depositary Share represents 13 Ordinary Shares. F6 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F13 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $141.70 to $142.6999, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares, sold at each separate price. F1 · ownership.nature: These securities are held by Oyler Investment LLC, of which 99% of the limited liability company interest is owned by a grantor retained annuity trust, of which the Reporting Person's father is a trustee, for which the Reporting Person disclaims beneficial ownership. Read SEC document |
| November 26, 2018 Filed Nov 29, 2018 00:26 UTC |
OYLER JOHNDirector · Chief Executive Officer
|
SaleAmerican Depositary Shares | 1,100 | $140.97 | $155,069.97 |
DisclosureSEC source: 0001651308-18-000010 · wf-form4_154345117115026.xml · nonDerivative · entry 11 OYLER JOHN · CIK 0001042047 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 25,060 F5 · security: Each American Depositary Share represents 13 Ordinary Shares. F6 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F12 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $140.62 to $141.6199, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares, sold at each separate price. F1 · ownership.nature: These securities are held by Oyler Investment LLC, of which 99% of the limited liability company interest is owned by a grantor retained annuity trust, of which the Reporting Person's father is a trustee, for which the Reporting Person disclaims beneficial ownership. Read SEC document |
| November 26, 2018 Filed Nov 29, 2018 00:26 UTC |
OYLER JOHNDirector · Chief Executive Officer
|
SaleAmerican Depositary Shares | 2,605 | $140.05 | $364,821.13 |
DisclosureSEC source: 0001651308-18-000010 · wf-form4_154345117115026.xml · nonDerivative · entry 10 OYLER JOHN · CIK 0001042047 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 26,160 F5 · security: Each American Depositary Share represents 13 Ordinary Shares. F6 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F11 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $139.52 to $140.5199, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares, sold at each separate price. F1 · ownership.nature: These securities are held by Oyler Investment LLC, of which 99% of the limited liability company interest is owned by a grantor retained annuity trust, of which the Reporting Person's father is a trustee, for which the Reporting Person disclaims beneficial ownership. Read SEC document |
| November 26, 2018 Filed Nov 29, 2018 00:26 UTC |
OYLER JOHNDirector · Chief Executive Officer
|
SaleAmerican Depositary Shares | 968 | $138.98 | $134,534.09 |
DisclosureSEC source: 0001651308-18-000010 · wf-form4_154345117115026.xml · nonDerivative · entry 9 OYLER JOHN · CIK 0001042047 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 28,765 F5 · security: Each American Depositary Share represents 13 Ordinary Shares. F6 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F10 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $138.47 to $139.4699, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares, sold at each separate price. F1 · ownership.nature: These securities are held by Oyler Investment LLC, of which 99% of the limited liability company interest is owned by a grantor retained annuity trust, of which the Reporting Person's father is a trustee, for which the Reporting Person disclaims beneficial ownership. Read SEC document |
| November 26, 2018 Filed Nov 29, 2018 00:26 UTC |
OYLER JOHNDirector · Chief Executive Officer
|
SaleAmerican Depositary Shares | 1,400 | $137.98 | $193,173.82 |
DisclosureSEC source: 0001651308-18-000010 · wf-form4_154345117115026.xml · nonDerivative · entry 8 OYLER JOHN · CIK 0001042047 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 29,733 F5 · security: Each American Depositary Share represents 13 Ordinary Shares. F6 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $137.39 to $138.3899, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares, sold at each separate price. F1 · ownership.nature: These securities are held by Oyler Investment LLC, of which 99% of the limited liability company interest is owned by a grantor retained annuity trust, of which the Reporting Person's father is a trustee, for which the Reporting Person disclaims beneficial ownership. Read SEC document |
| November 26, 2018 Filed Nov 29, 2018 00:26 UTC |
OYLER JOHNDirector · Chief Executive Officer
|
SaleAmerican Depositary Shares | 2,000 | $136.77 | $273,543.00 |
DisclosureSEC source: 0001651308-18-000010 · wf-form4_154345117115026.xml · nonDerivative · entry 7 OYLER JOHN · CIK 0001042047 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 31,133 F5 · security: Each American Depositary Share represents 13 Ordinary Shares. F6 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F8 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $136.35 to $137.3499, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares, sold at each separate price. F1 · ownership.nature: These securities are held by Oyler Investment LLC, of which 99% of the limited liability company interest is owned by a grantor retained annuity trust, of which the Reporting Person's father is a trustee, for which the Reporting Person disclaims beneficial ownership. Read SEC document |
| November 26, 2018 Filed Nov 29, 2018 00:26 UTC |
OYLER JOHNDirector · Chief Executive Officer
|
SaleAmerican Depositary Shares | 200 | $134.98 | $26,995.00 |
DisclosureSEC source: 0001651308-18-000010 · wf-form4_154345117115026.xml · nonDerivative · entry 6 OYLER JOHN · CIK 0001042047 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 33,133 F5 · security: Each American Depositary Share represents 13 Ordinary Shares. F6 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $134.97 to $135.9699, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares, sold at each separate price. F1 · ownership.nature: These securities are held by Oyler Investment LLC, of which 99% of the limited liability company interest is owned by a grantor retained annuity trust, of which the Reporting Person's father is a trustee, for which the Reporting Person disclaims beneficial ownership. Read SEC document |
| November 26, 2018 Filed Nov 29, 2018 00:25 UTC |
Huang JaneCMO, Hematology
|
Exercise / conversionShare Option (Right to Buy) · Derivative | 39,000 | $0.00 Strike: $2.27 | $0.00 |
DisclosureSEC source: 0001651308-18-000009 · wf-form4_154345108513198.xml · derivative · entry 4 Huang Jane · CIK 0001683913 · CMO, Hematology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,328,500 Underlying: Ordinary Shares · 39,000 shares Expires 2026-09-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_price: The number of securities underlying each option and the exercise price therefore are represented in ordinary shares. The exercise price is equal to 1/13 of the closing price of our ADSs on the date of grant, as each ADS represents 13 ordinary shares. F6 · derivative.exercise_date: These securities vest over a four-year period as follows: 25% on the first anniversary of September 2, 2016 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. All unvested shares subject to this option are subject to accelerated vesting upon certain termination events. Read SEC document |
| November 26, 2018 Filed Nov 29, 2018 00:25 UTC |
Huang JaneCMO, Hematology
|
SaleAmerican Depositary Shares | 3,000 | $139.58 | $418,750.20 |
DisclosureSEC source: 0001651308-18-000009 · wf-form4_154345108513198.xml · nonDerivative · entry 3 Huang Jane · CIK 0001683913 · CMO, Hematology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · security: Each American Depositary Share ("ADS") represents 13 Ordinary Shares. F3 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $139.5334 to $140.5333, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares, sold at each separate price. Read SEC document |
| November 26, 2018 Filed Nov 29, 2018 00:25 UTC |
Huang JaneCMO, Hematology
|
Exercise / conversionAmerican Depositary Shares | 3,000 | $29.49 | $88,470.00 |
DisclosureSEC source: 0001651308-18-000009 · wf-form4_154345108513198.xml · nonDerivative · entry 2 Huang Jane · CIK 0001683913 · CMO, Hematology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Each American Depositary Share ("ADS") represents 13 Ordinary Shares. F2 · price: The exercise price is reflected in ADSs. Read SEC document |
| November 19, 2018 Filed Nov 21, 2018 23:42 UTC |
Glazer Donald W.Director
|
GiftOrdinary Shares | 3,138 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-18-069636 · a4.xml · nonDerivative · entry 3 Glazer Donald W. · CIK 0001660940 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,127,526 F1 · price: Bona fide gift of shares which is exempt from Section 16(b) of the Exchange Act pursuant to Rule 16b-5. Read SEC document |
| November 19, 2018 Filed Nov 21, 2018 23:42 UTC |
Glazer Donald W.Director
|
GiftOrdinary Shares | 3,138 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-18-069636 · a4.xml · nonDerivative · entry 2 Glazer Donald W. · CIK 0001660940 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,130,664 F1 · price: Bona fide gift of shares which is exempt from Section 16(b) of the Exchange Act pursuant to Rule 16b-5. Read SEC document |
| November 19, 2018 Filed Nov 21, 2018 23:42 UTC |
Glazer Donald W.Director
|
GiftOrdinary Shares | 3,138 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-18-069636 · a4.xml · nonDerivative · entry 1 Glazer Donald W. · CIK 0001660940 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,133,802 F1 · price: Bona fide gift of shares which is exempt from Section 16(b) of the Exchange Act pursuant to Rule 16b-5. Read SEC document |
| November 19, 2018 Filed Nov 21, 2018 23:41 UTC |
Wang XiaodongDirector
|
SaleAmerican Depositary Shares | 600 | $126.53 | $75,918.00 |
DisclosureSEC source: 0001104659-18-069635 · a4.xml · nonDerivative · entry 5 Wang Xiaodong · CIK 0001662982 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $126.30 to $127.2999, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares, sold at each separate price. Read SEC document |
| November 19, 2018 Filed Nov 21, 2018 23:41 UTC |
Wang XiaodongDirector
|
SaleAmerican Depositary Shares | 850 | $125.56 | $106,727.53 |
DisclosureSEC source: 0001104659-18-069635 · a4.xml · nonDerivative · entry 4 Wang Xiaodong · CIK 0001662982 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 600 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $125.20 to $126.1999, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares, sold at each separate price. Read SEC document |
| November 19, 2018 Filed Nov 21, 2018 23:41 UTC |
Wang XiaodongDirector
|
SaleAmerican Depositary Shares | 1,173 | $124.55 | $146,098.32 |
DisclosureSEC source: 0001104659-18-069635 · a4.xml · nonDerivative · entry 3 Wang Xiaodong · CIK 0001662982 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,450 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $124.19 to $125.1899, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares, sold at each separate price. Read SEC document |
| November 19, 2018 Filed Nov 21, 2018 23:41 UTC |
Wang XiaodongDirector
|
SaleAmerican Depositary Shares | 1,277 | $123.68 | $157,944.98 |
DisclosureSEC source: 0001104659-18-069635 · a4.xml · nonDerivative · entry 2 Wang Xiaodong · CIK 0001662982 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,623 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $123.19 to $124.1899, inclusive. The Reporting Person has provided the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| November 19, 2018 Filed Nov 21, 2018 23:41 UTC |
Wang XiaodongDirector
|
SaleAmerican Depositary Shares | 1,100 | $122.55 | $134,801.04 |
DisclosureSEC source: 0001104659-18-069635 · a4.xml · nonDerivative · entry 1 Wang Xiaodong · CIK 0001662982 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,900 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $121.11 to $123.1099, inclusive. The Reporting Person has provided the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price. Read SEC document |
| November 12, 2018 Filed Nov 13, 2018 15:20 UTC |
Peterson Amy C.CMO, Immuno-oncology
|
Exercise / conversionShare Option (Right to Buy) · Derivative | 156,871 | $0.00 Strike: $2.24 | $0.00 |
DisclosureSEC source: 0001682735-18-000003 · wf-form4_154212240992906.xml · derivative · entry 27 Peterson Amy C. · CIK 0001682735 · CMO, Immuno-oncology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,080,000 Underlying: Ordinary Shares · 156,871 shares Expires 2026-08-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F24 · derivative.exercise_price: The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. F25 · derivative.exercise_date: These securities vest over a four-year period as follows: 25% on the first anniversary of August 22, 2016 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. All unvested shares subject to this option are subject to accelerated vesting upon certain termination events. Read SEC document |
| November 12, 2018 Filed Nov 13, 2018 15:20 UTC |
Peterson Amy C.CMO, Immuno-oncology
|
SaleAmerican Depositary Shares | 100 | $121.56 | $12,156.00 |
DisclosureSEC source: 0001682735-18-000003 · wf-form4_154212240992906.xml · nonDerivative · entry 24 Peterson Amy C. · CIK 0001682735 · CMO, Immuno-oncology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F3 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F23 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $121.56 to $122.5599, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares, sold at each separate price. Read SEC document |
| November 12, 2018 Filed Nov 13, 2018 15:20 UTC |
Peterson Amy C.CMO, Immuno-oncology
|
SaleAmerican Depositary Shares | 109 | $117.61 | $12,819.56 |
DisclosureSEC source: 0001682735-18-000003 · wf-form4_154212240992906.xml · nonDerivative · entry 23 Peterson Amy C. · CIK 0001682735 · CMO, Immuno-oncology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F3 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F22 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $116.84 to $117.8399, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares, sold at each separate price. Read SEC document |
| November 12, 2018 Filed Nov 13, 2018 15:20 UTC |
Peterson Amy C.CMO, Immuno-oncology
|
SaleAmerican Depositary Shares | 500 | $116.56 | $58,281.15 |
DisclosureSEC source: 0001682735-18-000003 · wf-form4_154212240992906.xml · nonDerivative · entry 22 Peterson Amy C. · CIK 0001682735 · CMO, Immuno-oncology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 209 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F3 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F21 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $115.82 to $116.8199, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares, sold at each separate price. Read SEC document |
| November 12, 2018 Filed Nov 13, 2018 15:20 UTC |
Peterson Amy C.CMO, Immuno-oncology
|
SaleAmerican Depositary Shares | 700 | $114.96 | $80,472.00 |
DisclosureSEC source: 0001682735-18-000003 · wf-form4_154212240992906.xml · nonDerivative · entry 21 Peterson Amy C. · CIK 0001682735 · CMO, Immuno-oncology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 709 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F3 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F20 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $114.63 to $115.6299, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares, sold at each separate price. Read SEC document |
| November 12, 2018 Filed Nov 13, 2018 15:20 UTC |
Peterson Amy C.CMO, Immuno-oncology
|
SaleAmerican Depositary Shares | 1,173 | $113.92 | $133,630.04 |
DisclosureSEC source: 0001682735-18-000003 · wf-form4_154212240992906.xml · nonDerivative · entry 20 Peterson Amy C. · CIK 0001682735 · CMO, Immuno-oncology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,409 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F3 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F19 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $113.63 to $114.6299, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares, sold at each separate price. Read SEC document |
| November 12, 2018 Filed Nov 13, 2018 15:20 UTC |
Peterson Amy C.CMO, Immuno-oncology
|
SaleAmerican Depositary Shares | 2,527 | $113.03 | $285,632.37 |
DisclosureSEC source: 0001682735-18-000003 · wf-form4_154212240992906.xml · nonDerivative · entry 19 Peterson Amy C. · CIK 0001682735 · CMO, Immuno-oncology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,582 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F3 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F18 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $112.61 to $113.6099, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares, sold at each separate price. Read SEC document |
| November 12, 2018 Filed Nov 13, 2018 15:20 UTC |
Peterson Amy C.CMO, Immuno-oncology
|
SaleAmerican Depositary Shares | 4,000 | $112.18 | $448,720.40 |
DisclosureSEC source: 0001682735-18-000003 · wf-form4_154212240992906.xml · nonDerivative · entry 18 Peterson Amy C. · CIK 0001682735 · CMO, Immuno-oncology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,109 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F3 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F17 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $111.61 to $112.6099, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depository Shares, sold at each separate price. Read SEC document |
| November 12, 2018 Filed Nov 13, 2018 15:20 UTC |
Peterson Amy C.CMO, Immuno-oncology
|
SaleAmerican Depositary Shares | 2,958 | $111.10 | $328,637.65 |
DisclosureSEC source: 0001682735-18-000003 · wf-form4_154212240992906.xml · nonDerivative · entry 17 Peterson Amy C. · CIK 0001682735 · CMO, Immuno-oncology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,109 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F3 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F16 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $110.50 to $111.4999, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares, sold at each separate price. Read SEC document |
| November 12, 2018 Filed Nov 13, 2018 15:20 UTC |
Peterson Amy C.CMO, Immuno-oncology
|
Exercise / conversionAmerican Depositary Shares | 12,067 | $29.10 | $351,149.70 |
DisclosureSEC source: 0001682735-18-000003 · wf-form4_154212240992906.xml · nonDerivative · entry 16 Peterson Amy C. · CIK 0001682735 · CMO, Immuno-oncology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,067 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · price: The exercise price is represented in American Depositary Shares. Read SEC document |
| November 09, 2018 Filed Nov 13, 2018 15:20 UTC |
Peterson Amy C.CMO, Immuno-oncology
|
Exercise / conversionShare Option (Right to Buy) · Derivative | 171,886 | $0.00 Strike: $2.24 | $0.00 |
DisclosureSEC source: 0001682735-18-000003 · wf-form4_154212240992906.xml · derivative · entry 26 Peterson Amy C. · CIK 0001682735 · CMO, Immuno-oncology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,236,871 Underlying: Ordinary Shares · 171,886 shares Expires 2026-08-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F24 · derivative.exercise_price: The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. F25 · derivative.exercise_date: These securities vest over a four-year period as follows: 25% on the first anniversary of August 22, 2016 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. All unvested shares subject to this option are subject to accelerated vesting upon certain termination events. Read SEC document |
| November 09, 2018 Filed Nov 13, 2018 15:20 UTC |
Peterson Amy C.CMO, Immuno-oncology
|
SaleAmerican Depositary Shares | 100 | $125.97 | $12,597.00 |
DisclosureSEC source: 0001682735-18-000003 · wf-form4_154212240992906.xml · nonDerivative · entry 15 Peterson Amy C. · CIK 0001682735 · CMO, Immuno-oncology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F3 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F15 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $125.97 to $126.9699, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares, sold at each separate price. Read SEC document |
| November 09, 2018 Filed Nov 13, 2018 15:20 UTC |
Peterson Amy C.CMO, Immuno-oncology
|
SaleAmerican Depositary Shares | 322 | $123.75 | $39,846.73 |
DisclosureSEC source: 0001682735-18-000003 · wf-form4_154212240992906.xml · nonDerivative · entry 14 Peterson Amy C. · CIK 0001682735 · CMO, Immuno-oncology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F3 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F14 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $123.50 to $124.4999, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares, sold at each separate price. Read SEC document |
| November 09, 2018 Filed Nov 13, 2018 15:20 UTC |
Peterson Amy C.CMO, Immuno-oncology
|
SaleAmerican Depositary Shares | 2,046 | $122.55 | $250,732.80 |
DisclosureSEC source: 0001682735-18-000003 · wf-form4_154212240992906.xml · nonDerivative · entry 13 Peterson Amy C. · CIK 0001682735 · CMO, Immuno-oncology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 422 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F3 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F13 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $122.21 to $123.2099, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares, sold at each separate price. Read SEC document |
| November 09, 2018 Filed Nov 13, 2018 15:20 UTC |
Peterson Amy C.CMO, Immuno-oncology
|
SaleAmerican Depositary Shares | 2,898 | $121.71 | $352,703.70 |
DisclosureSEC source: 0001682735-18-000003 · wf-form4_154212240992906.xml · nonDerivative · entry 12 Peterson Amy C. · CIK 0001682735 · CMO, Immuno-oncology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,468 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F3 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F12 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $121.18 to $122.1799, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares, sold at each separate price. Read SEC document |
| November 09, 2018 Filed Nov 13, 2018 15:20 UTC |
Peterson Amy C.CMO, Immuno-oncology
|
SaleAmerican Depositary Shares | 2,100 | $120.63 | $253,325.10 |
DisclosureSEC source: 0001682735-18-000003 · wf-form4_154212240992906.xml · nonDerivative · entry 11 Peterson Amy C. · CIK 0001682735 · CMO, Immuno-oncology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,366 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F3 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F11 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $120.14 to $121.1399, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares, sold at each separate price. Read SEC document |
| November 09, 2018 Filed Nov 13, 2018 15:20 UTC |
Peterson Amy C.CMO, Immuno-oncology
|
SaleAmerican Depositary Shares | 1,725 | $119.27 | $205,739.72 |
DisclosureSEC source: 0001682735-18-000003 · wf-form4_154212240992906.xml · nonDerivative · entry 10 Peterson Amy C. · CIK 0001682735 · CMO, Immuno-oncology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,466 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F3 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F10 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $119.01 to $120.0099, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares, sold at each separate price. Read SEC document |
| November 09, 2018 Filed Nov 13, 2018 15:20 UTC |
Peterson Amy C.CMO, Immuno-oncology
|
SaleAmerican Depositary Shares | 4,031 | $118.64 | $478,217.69 |
DisclosureSEC source: 0001682735-18-000003 · wf-form4_154212240992906.xml · nonDerivative · entry 9 Peterson Amy C. · CIK 0001682735 · CMO, Immuno-oncology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,191 F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F3 · kind: The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $118.01 to $119.0099, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares, sold at each separate price. Read SEC document |
| November 09, 2018 Filed Nov 13, 2018 15:20 UTC |
Peterson Amy C.CMO, Immuno-oncology
|
Exercise / conversionAmerican Depositary Shares | 13,222 | $29.10 | $384,760.20 |
DisclosureSEC source: 0001682735-18-000003 · wf-form4_154212240992906.xml · nonDerivative · entry 8 Peterson Amy C. · CIK 0001682735 · CMO, Immuno-oncology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,222 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Each American Depositary Share represents 13 Ordinary Shares. F2 · price: The exercise price is represented in American Depositary Shares. Read SEC document |
| November 08, 2018 Filed Nov 13, 2018 15:20 UTC |
Peterson Amy C.CMO, Immuno-oncology
|
Exercise / conversionShare Option (Right to Buy) · Derivative | 191,243 | $0.00 Strike: $2.24 | $0.00 |
DisclosureSEC source: 0001682735-18-000003 · wf-form4_154212240992906.xml · derivative · entry 25 Peterson Amy C. · CIK 0001682735 · CMO, Immuno-oncology 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,408,757 Underlying: Ordinary Shares · 191,243 shares Expires 2026-08-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F24 · derivative.exercise_price: The number of securities underlying each option and the exercise price therefor are represented in ordinary shares. F25 · derivative.exercise_date: These securities vest over a four-year period as follows: 25% on the first anniversary of August 22, 2016 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. All unvested shares subject to this option are subject to accelerated vesting upon certain termination events. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.